Osborne Partners Capital Management, LLC Gsk PLC Transaction History

Osborne Partners Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	BUY	$34.07 - $39.94 $870,181 - $1.02 Million	25,541 New	25,541 $940,000
Q1 2019 Apr 24, 2019	SELL	$38.57 - $42.69 $990,130 - $1.1 Million	-25,671 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$39.75 - $42.69 $10,414 - $11,184	-262 Reduced 1.01%	25,671 $1.03 Million
Q2 2018 Jul 19, 2018	BUY	$39.61 - $42.76 $10,377 - $11,203	262 Added 1.02%	25,933 $1.05 Million
Q1 2018 Apr 19, 2018	SELL	$36.18 - $40.15 $2,532 - $2,810	-70 Reduced 0.27%	25,671 $1 Million
Q4 2017 Jan 25, 2018	BUY	$35.34 - $41.9 $2,473 - $2,933	70 Added 0.27%	25,741 $913,000
Q3 2017 Oct 19, 2017	BUY	$39.44 - $41.55 $1.01 Million - $1.07 Million	25,671	25,671 $1.04 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.